Detalhe da pesquisa
1.
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
Nature
; 565(7738): E4, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30532003
2.
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
Nature
; 550(7674): 133-136, 2017 10 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28953887
3.
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors.
J Clin Invest
; 126(5): 1834-56, 2016 05 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27043285